期刊文献+

老年人心房颤动并发脑卒中的危险因素分析 预览 被引量:1

在线阅读 下载PDF
收藏 分享 导出
摘要 【目的】探讨老年人心房颤动并发脑卒中的危险因素。【方法】将101例老年房颤患者分为脑卒中组21例、对照组(无脑卒中组)80例.回顾性对比分析其病史、合并疾病、体征及辅助检查、用药情况。【结果】脑卒中组平均年龄(76.3±8.2)岁、≥75岁占57.1%,对照组平均年龄(68.1±9.4)岁、≥75岁占38.8%;脑卒中组持续性房颤16例(76.2%)、对照组49倒(61.3%);合并疾病脑卒中组中高血压痛9例(42.8%)、糖尿病4例(19.0%),对照组中高血压痛26例(32.5%)、糖尿病9例(11.3%);脑卒中组高胆固醇4例(19.0%)、对照组8例(10.0%);应用肠溶阿司匹林100mg/d,脑卒中组有10例(47.6%)、对照组有46例(57.5%),以上两组对照脑卒中危险因素差异显著(P(0.05)。【结论】年龄≥75岁、持续性房颤、高血压、糖尿病、高胆固醇是老年房颤并发脑卒中的危险因素,控制危险因素,合理应用抗凝、抗血小板药物有助于减少老年人心房颤动并发脑卒中的发生率。
出处 《医学临床研究》 CAS 2006年第7期 1114-1115,共2页 Journal of Clinical Research
  • 相关文献

参考文献5

  • 1陈灏珠.实用内科学[M].12版.北京:人民卫生出版社,2005:1030 被引量:16
  • 2Benjamin EJ,Wolf PA,Dagcstino RB,et al.Impact of atrial fibrillation on the risk of death:the Framingham heart study[J] Circulation,1998,98:946-952. 被引量:1
  • 3Atrial fibrillation invetigators:echocardiographic predictors of stroke in patients with atrial fibrillation:a prospective study of 1066 patients from three clinical trials.Arch Intern Med,1998,158:1316-1320 被引量:1
  • 4Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalscular atrial fibrillation.The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.Ann Intern Med,1998,128:639-647. 被引量:1
  • 5张学义,张薇,郑兆通,钟明,黎莉,张运.非瓣膜性心房颤动并发缺血性脑卒中的防治[J].中华急诊医学杂志,2004,13(9):592-594. 被引量:19

二级参考文献8

  • 1Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American Heart Association. Circulation, 2001, 103:163-182. 被引量:1
  • 2Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest, 1998,114(5 Suppl):5795-5895. 被引量:1
  • 3Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. A multicenter, prospective, randomized trial. Stroke, 2000, 31:817-821. 被引量:1
  • 4Levy S, Brelthardt G, Campbell RW, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J, 1998, 19:1294-1320. 被引量:1
  • 5Antiplatelet Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J, 2000, 324:71-86. 被引量:1
  • 6Hsievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation, 2002, 105:1887-1891. 被引量:1
  • 7Ezekowita MD, Levine JA. Preventing stoke in patients with atrial fibrillation. JAMA, 1999, 281: 1830-1835. 被引量:1
  • 8占成业,周代星,杨光田,邓普珍.胺碘酮与毛花甙C控制快速心房颤动伴充血性心力衰竭患者心室率即时效应及安全性的比较[J].中华急诊医学杂志,2003,12(3):188-190. 被引量:2

共引文献33

同被引文献15

引证文献1

二级引证文献11

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈